Daniel Newman Mendelson is Director of CHAMPIONS ONCOLOGY, INC.. Currently has a direct ownership of 198,625 shares of CSBR, which is worth approximately $1.5 Million. The most recent transaction as insider was on Feb 18, 2020, when has been sold 30,000 shares (Common Stock) at a price of $3.42 per share, resulting in proceeds of $102,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 199K
0% 3M change
9.93% 12M change
Total Value Held $1.5 Million

Daniel Newman Mendelson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 18 2020
BUY
Exercise of conversion of derivative security
$102,600 $3.42 p/Share
30,000 Added 19.59%
123,121 Common Stock
Feb 11 2020
BUY
Exercise of conversion of derivative security
$198,000 $5.76 p/Share
34,375 Added 25.0%
103,121 Common Stock
DNM

Daniel Newman Mendelson

Director
Hackensack, NJ

Track Institutional and Insider Activities on CSBR

Follow CHAMPIONS ONCOLOGY, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CSBR shares.

Notify only if

Insider Trading

Get notified when an Champions Oncology, Inc. insider buys or sells CSBR shares.

Notify only if

News

Receive news related to CHAMPIONS ONCOLOGY, INC.

Track Activities on CSBR